Preparation of recombinant RNase single-chain antibody fusion proteins.
This article describes the construction, expression, and purification of RNase single-chain antibody fusion proteins. To construct a fusion protein, the gene for each moiety, the RNase and the binding ligand, is modified separately to contain complementary DNA encoding a 13 amino acid spacer that separates the RNase from the binding moiety. Appropriate restriction enzyme sites for cloning into the vector are also added. The modified DNA is combined and fused using the PCR technique of splicing by overlap extension (1). The resulting DNA construct is expressed in inclusion bodies in BL21(DE3) bacteria that are specifically engineered for the expression of toxic proteins (2). After isolation and purification of the inclusion bodies, the fusion protein is solubilized, denatured, and renatured. The renatured RNase fusion protein mixture is purified to homogeneity by two chromatography steps. The first column, a CM-Sephadex C-50 or a heparin Sepharose column, eliminates the majority of contaminating proteins while the second column, an affinity column (Ni2+-NTA agarose), results in the final purification of the RNase fusion protein.
Newton
Dianne L
DL
SAIC Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, MD 21702, USA.
Rybak
Susanna M
SM
D000818:Animals; D000906:Antibodies / Q000235:genetics*; D002845:Chromatography / Q000379:methods; D006801:Humans; D018796:Immunoconjugates / Q000235:genetics* / Q000378:metabolism; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D011993:Recombinant Fusion Proteins / Q000235:genetics* / Q000302:isolation & purification; D012260:Ribonucleases / Q000235:genetics*
D000906:Antibodies; D018796:Immunoconjugates; D011993:Recombinant Fusion Proteins; D012260:Ribonucleases